Center for Opioid Epidemiology & Policy Events | NYU Langone Health

Skip to Main Content
Center for Opioid Epidemiology & Policy Center for Opioid Epidemiology & Policy Events

Center for Opioid Epidemiology & Policy Events

NYU Langone’s Center for Opioid Epidemiology and Policy hosts several seminars each year to share our research findings, explain new areas of study, and advance the field of opioid-related research.

To stay up to date with developments in opioid epidemiology and policy, please join our mailing list.

2021 Virtual Seminars

Please revisit this page in the coming weeks as we confirm more events for 2021.

Past Seminars

Past seminars at the Center for Opioid Epidemiology and Policy have featured a wide range of speakers in the public health and healthcare policy field.

Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients

Rosanna Smart, PhD, an economist at RAND, discussed recent work evaluating the effects of state naloxone access laws (NALs) on pharmacy dispensing of naloxone, opioid-related hospitalizations, and fatal opioid-related overdose. Distinguishing between different types of NALs that allow individuals to obtain naloxone from a pharmacy without a patient-specific prescription from another provider, she presented preliminary results using newly developed causal inference methods that account for heterogeneous effects across states and over time in the context of staggered policy adoption.

Black Communities in the Opioid Crisis

Ayana Jordan, MD, PhD, an associate psychiatry residency program director, assistant professor, and addiction psychiatrist at Yale University, is a community-engaged researcher focused on providing equitable mental health and addiction treatment and preventative services for historically marginalized populations. In her talk, Black Communities in the Opioid Crisis, Dr. Jordan discussed the results of her research, educational, and clinical work focused on increasing access to evidence-based substance use treatment for marginalized populations. Specifically, she presented the results of her pilot study providing addiction treatment in the Black church setting, and the faith-based recovery project, Imani Breakthrough (Imani meaning faith in Swahili). Both initiatives were held in eight Black and Latinx churches throughout the state of Connecticut that help Black and Latinx individuals with addiction engage in treatment.

Health Disparities Among Rural People Who Use Drugs—Possible Negative Impacts of COVID-19

Wiley D. Jenkins, PhD, MPH, associate professor and chief of epidemiology and biostatistics at Southern Illinois University School of Medicine, discussed the results of the first phase of his current clinical trial addressing infectious disease among rural people who use drugs (PWUD). Results of data from 175 PWUD were presented and linked to the phase II efforts. Dr. Jenkins also discussed the potential impact of the COVID-19 pandemic on PWUD health.

Ethnographic Assessment of Drug Use and Related Services Across 18 Maryland Counties

Danielle German, PhD, MPH, associate professor at Johns Hopkins Bloomberg School of Public Health, presented results from a statewide ethnographic assessment of drug use and services conducted in Maryland in 2019, focusing on the 18 Western, Central, and Eastern Shore counties. This applied research study explored drug use experiences and patterns, existing service capacity and barriers, and potential for harm reduction expansion from the perspective of people who use drugs and stakeholders in each county.

National and State Estimates of the U.S. Opioid Epidemic's Impact on Children

Suzanne Brundage, MS, director of the Children's Health Initiative at the United Hospital Fund, presented on an analysis of the impact of the opioid epidemic on children. Ms. Brundage discussed the key finding that the nation's opioid epidemic placed an estimated 2.2 million children and adolescents in crisis as of 2017, how the epidemic has differentially affected children across states, and long-term societal implications.

Rural Communities in Crisis: Leveraging Research to Inform Drug Policy and Practice

Sean T. Allen, DrPH, MPH, a faculty member at the Johns Hopkins Bloomberg School of Public Health, presented on his work examining injection drug use-associated health disparities in rural Appalachia. Dr. Allen discussed the adaptation of population size estimation methodologies to rural contexts and the application of research evidence to address emerging infectious disease outbreaks among people who inject drugs.

Cost-Effectiveness of Care Models to Support HCV and HIV Elimination in People Who Inject Drugs

Bruce Schackman, PhD, MBA, professor, and Czarina Navos Behrends, PhD, MPH, assistant professor of healthcare policy and research at Weill Cornell Medical College, presented on recent work evaluating the cost-effectiveness and implementation of healthcare models designed to bring HCV/HIV testing and HCV care to people who inject drugs in substance use disorder treatment programs and syringe service programs.

Reaching the Hard-to-Reach: Methodological Challenges and Solutions for Measuring the Prevalence of Street Drug Use and Hepatitis C in Brazil

Francisco Bastos, PhD, MD, a senior researcher at the Fundação Oswaldo Cruz (Fiocruz) Foundation, discussed challenges in reaching and estimating the size of hard-to-reach populations. Dr. Bastos gave insight on the strong points and caveats of several methods for finding, testing, counseling, and treating people living with hepatitis C.

Responding to Opioid Use Disorder: Evidence, Treatment, and Public Policy

Chelsea L. Shover, PhD, a postdoctoral research fellow at the Stanford University School of Medicine, presented on implementation and policy challenges when providing evidence-based opioid use disorder treatment, including slow uptake of long-acting medications for opioid use disorder and cannabis laws.

Losing Your License to Drink: Evaluating the Public Health Implications of 24/7 Sobriety Programs

Beau Kilmer, PhD, MPP, director and senior policy researcher at RAND Drug Policy Research Center, reported on his recent work measuring the effects of 24/7 sobriety programs. His research lies at the intersection of public health and public safety, with special emphasis on crime control, substance use, illicit markets, and public policy.

Social Epidemiology and the Opioid Crisis: Study Design, Findings, and Works in Progress

Alex Bennett, PhD, and Luther Elliott, PhD, associate research scientists at NYU College of Global Public Health, presented their ongoing research with military veterans, opioid agonist therapy patients, and other populations as well as potential interventions targeting stigma, burnout, and lack of education on addiction and opioid treatment.

Contact Us

For all inquiries, please contact Caroline Barnes, MPH, senior program manager, at